采访外科肿瘤学家罗伯特·n·格里夫医生

IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL
C. Woodford
{"title":"采访外科肿瘤学家罗伯特·n·格里夫医生","authors":"C. Woodford","doi":"10.5015/UTMJ.V87I3.1264","DOIUrl":null,"url":null,"abstract":"Dr. Robert N. Gryfe is a colorectal surgical oncologist at Mount Sinai and Princess Margaret Hospitals and researcher at Mount Sinai’s Samuel Lunenfeld Research Institute. Dr. Gryfe's clinical practice specializes in the management of patients with colon and rectal cancer and hereditary cancer syndromes. His research laboratory investigates the genetic determinants of colorectal cancer risk, prognosis and response to chemotherapy.","PeriodicalId":41298,"journal":{"name":"University of Toronto Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2010-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An Interview with Dr. Robert N. Gryfe, Surgical Oncologist\",\"authors\":\"C. Woodford\",\"doi\":\"10.5015/UTMJ.V87I3.1264\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dr. Robert N. Gryfe is a colorectal surgical oncologist at Mount Sinai and Princess Margaret Hospitals and researcher at Mount Sinai’s Samuel Lunenfeld Research Institute. Dr. Gryfe's clinical practice specializes in the management of patients with colon and rectal cancer and hereditary cancer syndromes. His research laboratory investigates the genetic determinants of colorectal cancer risk, prognosis and response to chemotherapy.\",\"PeriodicalId\":41298,\"journal\":{\"name\":\"University of Toronto Medical Journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2010-06-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"University of Toronto Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5015/UTMJ.V87I3.1264\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"University of Toronto Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5015/UTMJ.V87I3.1264","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

Robert N. Gryfe博士是Mount Sinai和Princess Margaret Hospitals的结直肠外科肿瘤学家,Mount Sinai ' s Samuel Lunenfeld Research Institute的研究员。Gryfe博士的临床实践专长于结肠癌、直肠癌和遗传性癌症综合征患者的管理。他的研究实验室研究结直肠癌风险、预后和化疗反应的遗传决定因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
An Interview with Dr. Robert N. Gryfe, Surgical Oncologist
Dr. Robert N. Gryfe is a colorectal surgical oncologist at Mount Sinai and Princess Margaret Hospitals and researcher at Mount Sinai’s Samuel Lunenfeld Research Institute. Dr. Gryfe's clinical practice specializes in the management of patients with colon and rectal cancer and hereditary cancer syndromes. His research laboratory investigates the genetic determinants of colorectal cancer risk, prognosis and response to chemotherapy.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
University of Toronto Medical Journal
University of Toronto Medical Journal MEDICINE, GENERAL & INTERNAL-
CiteScore
0.30
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信